| FANIX | MLOAX | FANIX / MLOAX | |
| Total Expense Ratio | 0.71 | 1.25 | 57% |
| Annual Report Gross Expense Ratio | 0.71 | 1.65 | 43% |
| Fund Existence | 30 years | 12 years | - |
| Gain YTD | 12.889 | 18.797 | 69% |
| Front Load | N/A | 5% | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 895M | 122M | 734% |
| Annual Yield % from dividends | 0.91 | 4.07 | 22% |
| Returns for 1 year | 5.06 | 13.53 | 37% |
| Returns for 3 years | 13.68 | 40.33 | 34% |
| Returns for 5 years | 223.72 | 157.88 | 142% |
| Returns for 10 years | 84.75 | 111.03 | 76% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FGSAX | 61.94 | 0.07 | +0.11% |
| Federated Hermes MDT Mid Cap Growth A | |||
| CNPSX | 60.17 | N/A | N/A |
| Consumer Staples UltraSector ProFund Svc | |||
| FMFMX | 18.02 | N/A | N/A |
| Fidelity Advisor Series Equity Gr | |||
| IVITX | 19.74 | -0.03 | -0.15% |
| VY® Invesco Growth and Income S2 | |||
| BRWSX | 28.05 | -0.32 | -1.13% |
| MFS Blended Research Growth Eq R2 | |||